
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Hydrolyzed Collagen
Therapeutic Area : Musculoskeletal
Study Phase : Phase I
Recipient : Nealth Sarl
Deal Size : Inapplicable
Deal Type : Inapplicable
Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women
Details : Hydrolyzed Collagen is a drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Osteoporosis.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 10, 2011
Lead Product(s) : Hydrolyzed Collagen
Therapeutic Area : Musculoskeletal
Highest Development Status : Phase I
Recipient : Nealth Sarl
Deal Size : Inapplicable
Deal Type : Inapplicable
